Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy
- PMID: 23929778
- PMCID: PMC3780870
- DOI: 10.1073/pnas.1310657110
Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Comment in
-
Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3547. doi: 10.1073/pnas.1311721110. Proc Natl Acad Sci U S A. 2013. PMID: 24171201 Free PMC article. No abstract available.
Comment on
-
General mechanism for modulating immunoglobulin effector function.Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72. doi: 10.1073/pnas.1307864110. Epub 2013 May 22. Proc Natl Acad Sci U S A. 2013. PMID: 23697368 Free PMC article.
References
-
- Yu X, Vasiljevic S, Mitchell DA, Crispin M, Scanlan CN. Dissecting the molecular mechanism of IVIg therapy: The interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J Mol Biol. 2013;425(8):1253–1258. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources